Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

4.76
Delayed Data
As of Apr 20
 -0.08 / -1.65%
Today’s Change
3.92
Today|||52-Week Range
8.38
+2.37%
Year-to-Date
No recent news for Keryx Biopharmaceuticals Inc.

Today’s Trading

Previous close4.84
Today’s open4.85
Day’s range4.76 - 4.90
Volume659,527
Average volume (3 months)1,320,173
Market cap$593.5M
Data as of 4:00pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)+5.92%
Earnings growth (this year)+58.25%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+89.60%
P/E ratioNM
Price/Sales8.78
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PTCTPTC Therapeutics Inc+0.13+0.50%
TGTXTG Therapeutics Inc-0.30-2.04%
BYSIBeyondspring Inc+3.60+13.09%
EGRXEagle Pharmaceutical...-0.22-0.40%
Data as of 4:00pm ET, 04/20/2018

Financials

Next reporting dateMay 9, 2018
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$60.6M
Annual profit (last year)-$163.4M
Net profit margin-269.52%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Gregory P. Madison
Chief Operating Officer &
Senior Vice President
Christine A. Carberry
Corporate headquarters
Boston, Massachusetts

Forecasts